Inhibition of microRNA-21 increases radiosensitivity of esophageal cancer cells through phosphatase and tensin homolog deleted on chromosome 10 activation-Reference-Cited by-同舟云学术

Inhibition of microRNA-21 increases radiosensitivity of esophageal cancer cells through phosphatase and tensin homolog deleted on chromosome 10 activation

Published:2012-09-07 Issue:8 Volume:26 Page:823-831
ISSN:1120-8694
Container-title:Diseases of the Esophagus
language:en
Short-container-title:Dis Esophagus

Author:

Huang S.,Li X-Q.,Chen Xin,Che S-M.,Chen W.,Zhang X-Z.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/dote/article-pdf/26/8/823/10397268/dote0823.pdf

Reference29 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Oncomirs-microRNAs with a role in cancer;Esquela-Kerscher;Nat Rev Cancer,2006

3. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer;Petrocca;Cancer Cell,2008

4. MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of AKT phosphorylation;Lee;Oncogene,2009

5. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs;Chang;Nat Cell Biol,2011

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNA biomarkers in cancer therapeutics: The promise of personalized oncology;Advances in Clinical Chemistry;2024

2. Downregulation of Claudin5 promotes malignant progression and radioresistance through Beclin1-mediated autophagy in esophageal squamous cell carcinoma;Journal of Translational Medicine;2023-06-11

3. The role of microRNA-21 (miR-21) in pathogenesis, diagnosis, and prognosis of gastrointestinal cancers: A review;Life Sciences;2023-03

4. Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents;Pharmacological Research;2023-01

5. Downregulation of miR-21 as a promising strategy to overcome drug resistance in cancer;European Journal of Pharmacology;2022-10